logo-loader

CanaFarma Hemp Products developing bioequivalent drug to Hydroxychloroquine with partner PharmOps

Published: 13:06 12 Jun 2020 EDT

Canafarma Hemp Products Corp (CSE:CNFA) COO Frank Barone tells Proactive the firm is teaming up with private drugs group PharmOps to develop a bioequivalent drug to Hydroxychloroquine amid the coronavirus pandemic.

Barone says while there are controversies surrounding Hydroxychloroquine's effectiveness in the fight against coronavirus, he says there is a 'sizable demand' for the product.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

4 hours, 5 minutes ago